UCSD - Altman Clinical and Translational Research Institute (ACTRI)

La Jolla, California 92037-7410

3 studies enrolling now · 6 studies all time

What they study most

Amyloid, Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases, Cognitive Dysfunction, Elevated Lp(a), Lewy Body Disease, Lipoprotein(a), Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Synucleinopathies, Type 2 Diabetes Mellitus

Studies at this site

• A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed